• Caisson’s patented HEPtune® technology improves the half-life of peptides, proteins, and small molecule drugs.

    Slide 3
  • Caisson applies HEPtune® linker technology to enhanced antibody drug conjugates (ADCs).

    Slide 2
  • HEPboost enhances nanoparticle (liponanoparticles, liposomes, gold) uptake in immune cells.

    Slide 1

Caisson Biotech has developed a novel heparosan-based drug delivery platform, Heptune, to enhance the performance of therapeutics. Heparosan is a naturally occurring sugar polymer with low risk of toxicity and immunogenicity.